330 related articles for article (PubMed ID: 28886699)
1. Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke.
Shichinohe H; Kawabori M; Iijima H; Teramoto T; Abumiya T; Nakayama N; Kazumata K; Terasaka S; Arato T; Houkin K
BMC Neurol; 2017 Sep; 17(1):179. PubMed ID: 28886699
[TBL] [Abstract][Full Text] [Related]
2. Intracerebral transplantation of MRI-trackable autologous bone marrow stromal cells for patients with subacute ischemic stroke.
Kawabori M; Kuroda S; Shichinohe H; Kahata K; Shiratori S; Ikeda S; Harada T; Hirata K; Tha KK; Aragaki M; Terasaka S; Ito YM; Nishimoto N; Ohnishi S; Yabe I; Kudo K; Houkin K; Fujimura M
Med; 2024 May; 5(5):432-444.e4. PubMed ID: 38547868
[TBL] [Abstract][Full Text] [Related]
3. Cell Therapy for Stroke: Review of Previous Clinical Trials and Introduction of Our New Trials.
Shichinohe H; Houkin K
Neurol Med Chir (Tokyo); 2016 Oct; 56(10):592-596. PubMed ID: 27302193
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial.
Moniche F; Escudero I; Zapata-Arriaza E; Usero-Ruiz M; Prieto-León M; de la Torre J; Gamero MA; Tamayo JA; Ochoa-Sepúlveda JJ; Maestre J; Carmona M; Piñero P; Calderón-Cabrera C; Jimenez MD; Gonzalez A; Montaner J
Int J Stroke; 2015 Oct; 10(7):1149-52. PubMed ID: 26044701
[TBL] [Abstract][Full Text] [Related]
5. Short-, middle- and long-term safety of superparamagnetic iron oxide-labeled allogeneic bone marrow stromal cell transplantation in rat model of lacunar infarction.
Tan C; Shichinohe H; Abumiya T; Nakayama N; Kazumata K; Hokari M; Hamauchi S; Houkin K
Neuropathology; 2015 Jun; 35(3):197-208. PubMed ID: 25376270
[TBL] [Abstract][Full Text] [Related]
6. Transfection of Noggin in bone marrow stromal cells (BMSCs) enhances BMSC-induced functional outcome after stroke in rats.
Chen C; Cheng Y; Chen J
J Neurosci Res; 2011 Aug; 89(8):1194-202. PubMed ID: 21544853
[TBL] [Abstract][Full Text] [Related]
7. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.
Wei N; Yu SP; Gu X; Taylor TM; Song D; Liu XF; Wei L
Cell Transplant; 2013; 22(6):977-91. PubMed ID: 23031629
[TBL] [Abstract][Full Text] [Related]
8. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
9. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial.
Prasad K; Sharma A; Garg A; Mohanty S; Bhatnagar S; Johri S; Singh KK; Nair V; Sarkar RS; Gorthi SP; Hassan KM; Prabhakar S; Marwaha N; Khandelwal N; Misra UK; Kalita J; Nityanand S;
Stroke; 2014 Dec; 45(12):3618-24. PubMed ID: 25378424
[TBL] [Abstract][Full Text] [Related]
10. Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial.
Vahidy FS; Haque ME; Rahbar MH; Zhu H; Rowan P; Aisiku IP; Lee DA; Juneja HS; Alderman S; Barreto AD; Suarez JI; Bambhroliya A; Hasan KM; Kassam MR; Aronowski J; Gee A; Cox CS; Grotta JC; Savitz SI
Stem Cells; 2019 Nov; 37(11):1481-1491. PubMed ID: 31529663
[TBL] [Abstract][Full Text] [Related]
11. TOOTH (The Open study Of dental pulp stem cell Therapy in Humans): Study protocol for evaluating safety and feasibility of autologous human adult dental pulp stem cell therapy in patients with chronic disability after stroke.
Nagpal A; Kremer KL; Hamilton-Bruce MA; Kaidonis X; Milton AG; Levi C; Shi S; Carey L; Hillier S; Rose M; Zacest A; Takhar P; Koblar SA
Int J Stroke; 2016 Jul; 11(5):575-85. PubMed ID: 27030504
[TBL] [Abstract][Full Text] [Related]
12. Treatment evaluation of acute stroke for using in regenerative cell elements (TREASURE) trial: Rationale and design.
Osanai T; Houkin K; Uchiyama S; Minematsu K; Taguchi A; Terasaka S
Int J Stroke; 2018 Jun; 13(4):444-448. PubMed ID: 29134924
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic Preconditioning Augments the Therapeutic Efficacy of Bone Marrow Stromal Cells in a Rat Ischemic Stroke Model.
Chen J; Yang Y; Shen L; Ding W; Chen X; Wu E; Cai K; Wang G
Cell Mol Neurobiol; 2017 Aug; 37(6):1115-1129. PubMed ID: 27858286
[TBL] [Abstract][Full Text] [Related]
14. Delayed and repeated intranasal delivery of bone marrow stromal cells increases regeneration and functional recovery after ischemic stroke in mice.
Chau MJ; Deveau TC; Gu X; Kim YS; Xu Y; Yu SP; Wei L
BMC Neurosci; 2018 Apr; 19(1):20. PubMed ID: 29649974
[TBL] [Abstract][Full Text] [Related]
15. Sodium Ferulate combined with bone marrow stromal cell treatment ameliorating rat brain ischemic injury after stroke.
Zhao Y; Guan Y; Xu Y; Li Y; Wu W
Brain Res; 2012 Apr; 1450():157-65. PubMed ID: 22424793
[TBL] [Abstract][Full Text] [Related]
16. Restoration of intracortical and thalamocortical circuits after transplantation of bone marrow mesenchymal stem cells into the ischemic brain of mice.
Song M; Mohamad O; Gu X; Wei L; Yu SP
Cell Transplant; 2013; 22(11):2001-15. PubMed ID: 23069268
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of micron-sized superparamagnetic iron oxide particles as markers for detection of migration of bone marrow-derived mesenchymal stromal cells in a stroke model.
Tarulli E; Chaudhuri JD; Gretka V; Hoyles A; Morshead CM; Stanisz GJ
J Magn Reson Imaging; 2013 Jun; 37(6):1409-18. PubMed ID: 23712844
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
[TBL] [Abstract][Full Text] [Related]
19. Sodium ferulate and n-butylidenephthalate combined with bone marrow stromal cells (BMSCs) improve the therapeutic effects of angiogenesis and neurogenesis after rat focal cerebral ischemia.
Zhang Q; Zhao Y; Xu Y; Chen Z; Liu N; Ke C; Liu B; Wu W
J Transl Med; 2016 Jul; 14(1):223. PubMed ID: 27465579
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial.
Deng L; Peng Q; Wang H; Pan J; Zhou Y; Pan K; Li J; Wu Y; Wang Y
Transl Stroke Res; 2019 Apr; 10(2):170-177. PubMed ID: 29796934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
